Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of marav...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Scarpazza, Cristina [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A new global analytical potential energy surface of NaH - Yuan, Meiling ELSEVIER, 2018, official journal of the World Federation of Neurology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:378 ; year:2017 ; day:15 ; month:07 ; pages:233-237 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jns.2017.05.018 |
|---|
| Katalog-ID: |
ELV015537668 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV015537668 | ||
| 003 | DE-627 | ||
| 005 | 20230623122838.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jns.2017.05.018 |2 doi | |
| 028 | 5 | 2 | |a GBVA2017021000008.pica |
| 035 | |a (DE-627)ELV015537668 | ||
| 035 | |a (ELSEVIER)S0022-510X(17)30314-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.10 |2 bkl | ||
| 100 | 1 | |a Scarpazza, Cristina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| 264 | 1 | |c 2017 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. | ||
| 700 | 1 | |a Prosperini, Luca |4 oth | |
| 700 | 1 | |a Mancinelli, Chiara R. |4 oth | |
| 700 | 1 | |a De Rossi, Nicola |4 oth | |
| 700 | 1 | |a Lugaresi, Alessandra |4 oth | |
| 700 | 1 | |a Capobianco, Marco |4 oth | |
| 700 | 1 | |a Moiola, Lucia |4 oth | |
| 700 | 1 | |a Naldi, Paola |4 oth | |
| 700 | 1 | |a Imberti, Luisa |4 oth | |
| 700 | 1 | |a Gerevini, Simonetta |4 oth | |
| 700 | 1 | |a Capra, Ruggero |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Yuan, Meiling ELSEVIER |t A new global analytical potential energy surface of NaH |d 2018 |d official journal of the World Federation of Neurology |g Amsterdam [u.a.] |w (DE-627)ELV001315870 |
| 773 | 1 | 8 | |g volume:378 |g year:2017 |g day:15 |g month:07 |g pages:233-237 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jns.2017.05.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.10 |j Physikalische Chemie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 378 |j 2017 |b 15 |c 0715 |h 233-237 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
c s cs |
|---|---|
| matchkey_str |
scarpazzacristinaprosperinilucamancinell:2017----:saaioueuimlilslrssainsihaaiuarltdrgesvm |
| hierarchy_sort_str |
2017 |
| bklnumber |
35.10 |
| publishDate |
2017 |
| allfields |
10.1016/j.jns.2017.05.018 doi GBVA2017021000008.pica (DE-627)ELV015537668 (ELSEVIER)S0022-510X(17)30314-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Scarpazza, Cristina verfasserin aut Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. Prosperini, Luca oth Mancinelli, Chiara R. oth De Rossi, Nicola oth Lugaresi, Alessandra oth Capobianco, Marco oth Moiola, Lucia oth Naldi, Paola oth Imberti, Luisa oth Gerevini, Simonetta oth Capra, Ruggero oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 https://doi.org/10.1016/j.jns.2017.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 378 2017 15 0715 233-237 5 045F 610 |
| spelling |
10.1016/j.jns.2017.05.018 doi GBVA2017021000008.pica (DE-627)ELV015537668 (ELSEVIER)S0022-510X(17)30314-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Scarpazza, Cristina verfasserin aut Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. Prosperini, Luca oth Mancinelli, Chiara R. oth De Rossi, Nicola oth Lugaresi, Alessandra oth Capobianco, Marco oth Moiola, Lucia oth Naldi, Paola oth Imberti, Luisa oth Gerevini, Simonetta oth Capra, Ruggero oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 https://doi.org/10.1016/j.jns.2017.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 378 2017 15 0715 233-237 5 045F 610 |
| allfields_unstemmed |
10.1016/j.jns.2017.05.018 doi GBVA2017021000008.pica (DE-627)ELV015537668 (ELSEVIER)S0022-510X(17)30314-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Scarpazza, Cristina verfasserin aut Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. Prosperini, Luca oth Mancinelli, Chiara R. oth De Rossi, Nicola oth Lugaresi, Alessandra oth Capobianco, Marco oth Moiola, Lucia oth Naldi, Paola oth Imberti, Luisa oth Gerevini, Simonetta oth Capra, Ruggero oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 https://doi.org/10.1016/j.jns.2017.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 378 2017 15 0715 233-237 5 045F 610 |
| allfieldsGer |
10.1016/j.jns.2017.05.018 doi GBVA2017021000008.pica (DE-627)ELV015537668 (ELSEVIER)S0022-510X(17)30314-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Scarpazza, Cristina verfasserin aut Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. Prosperini, Luca oth Mancinelli, Chiara R. oth De Rossi, Nicola oth Lugaresi, Alessandra oth Capobianco, Marco oth Moiola, Lucia oth Naldi, Paola oth Imberti, Luisa oth Gerevini, Simonetta oth Capra, Ruggero oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 https://doi.org/10.1016/j.jns.2017.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 378 2017 15 0715 233-237 5 045F 610 |
| allfieldsSound |
10.1016/j.jns.2017.05.018 doi GBVA2017021000008.pica (DE-627)ELV015537668 (ELSEVIER)S0022-510X(17)30314-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Scarpazza, Cristina verfasserin aut Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. Prosperini, Luca oth Mancinelli, Chiara R. oth De Rossi, Nicola oth Lugaresi, Alessandra oth Capobianco, Marco oth Moiola, Lucia oth Naldi, Paola oth Imberti, Luisa oth Gerevini, Simonetta oth Capra, Ruggero oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 https://doi.org/10.1016/j.jns.2017.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 378 2017 15 0715 233-237 5 045F 610 |
| language |
English |
| source |
Enthalten in A new global analytical potential energy surface of NaH Amsterdam [u.a.] volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 |
| sourceStr |
Enthalten in A new global analytical potential energy surface of NaH Amsterdam [u.a.] volume:378 year:2017 day:15 month:07 pages:233-237 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Physikalische Chemie: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
A new global analytical potential energy surface of NaH |
| authorswithroles_txt_mv |
Scarpazza, Cristina @@aut@@ Prosperini, Luca @@oth@@ Mancinelli, Chiara R. @@oth@@ De Rossi, Nicola @@oth@@ Lugaresi, Alessandra @@oth@@ Capobianco, Marco @@oth@@ Moiola, Lucia @@oth@@ Naldi, Paola @@oth@@ Imberti, Luisa @@oth@@ Gerevini, Simonetta @@oth@@ Capra, Ruggero @@oth@@ |
| publishDateDaySort_date |
2017-01-15T00:00:00Z |
| hierarchy_top_id |
ELV001315870 |
| dewey-sort |
3610 |
| id |
ELV015537668 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV015537668</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623122838.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jns.2017.05.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017021000008.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV015537668</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-510X(17)30314-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.10</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Scarpazza, Cristina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prosperini, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mancinelli, Chiara R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Rossi, Nicola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lugaresi, Alessandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Capobianco, Marco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moiola, Lucia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naldi, Paola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Imberti, Luisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerevini, Simonetta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Capra, Ruggero</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Yuan, Meiling ELSEVIER</subfield><subfield code="t">A new global analytical potential energy surface of NaH</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the World Federation of Neurology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001315870</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:378</subfield><subfield code="g">year:2017</subfield><subfield code="g">day:15</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:233-237</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jns.2017.05.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.10</subfield><subfield code="j">Physikalische Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">378</subfield><subfield code="j">2017</subfield><subfield code="b">15</subfield><subfield code="c">0715</subfield><subfield code="h">233-237</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Scarpazza, Cristina |
| spellingShingle |
Scarpazza, Cristina ddc 610 ddc 540 bkl 35.10 Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| authorStr |
Scarpazza, Cristina |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001315870 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 VZ 35.10 bkl Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| topic |
ddc 610 ddc 540 bkl 35.10 |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.10 |
| topic_browse |
ddc 610 ddc 540 bkl 35.10 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l p lp c r m cr crm r n d rn rnd a l al m c mc l m lm p n pn l i li s g sg r c rc |
| hierarchy_parent_title |
A new global analytical potential energy surface of NaH |
| hierarchy_parent_id |
ELV001315870 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
A new global analytical potential energy surface of NaH |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001315870 |
| title |
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| ctrlnum |
(DE-627)ELV015537668 (ELSEVIER)S0022-510X(17)30314-3 |
| title_full |
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| author_sort |
Scarpazza, Cristina |
| journal |
A new global analytical potential energy surface of NaH |
| journalStr |
A new global analytical potential energy surface of NaH |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
233 |
| author_browse |
Scarpazza, Cristina |
| container_volume |
378 |
| physical |
5 |
| class |
610 610 DE-600 540 VZ 35.10 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Scarpazza, Cristina |
| doi_str_mv |
10.1016/j.jns.2017.05.018 |
| dewey-full |
610 540 |
| title_sort |
is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| title_auth |
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| abstract |
Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. |
| abstractGer |
Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. |
| abstract_unstemmed |
Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? |
| url |
https://doi.org/10.1016/j.jns.2017.05.018 |
| remote_bool |
true |
| author2 |
Prosperini, Luca Mancinelli, Chiara R. De Rossi, Nicola Lugaresi, Alessandra Capobianco, Marco Moiola, Lucia Naldi, Paola Imberti, Luisa Gerevini, Simonetta Capra, Ruggero |
| author2Str |
Prosperini, Luca Mancinelli, Chiara R. De Rossi, Nicola Lugaresi, Alessandra Capobianco, Marco Moiola, Lucia Naldi, Paola Imberti, Luisa Gerevini, Simonetta Capra, Ruggero |
| ppnlink |
ELV001315870 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jns.2017.05.018 |
| up_date |
2024-07-06T17:56:29.497Z |
| _version_ |
1803853328022503424 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV015537668</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623122838.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jns.2017.05.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017021000008.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV015537668</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-510X(17)30314-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.10</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Scarpazza, Cristina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the recent advances in the understanding of natalizumab (NTZ) related progressive multifocal leukoencephalopathy (PML) and its associated immune reconstitution inflammatory syndrome (PML-IRIS), the therapeutic options are still under investigated. In this context, the beneficial use of maraviroc is still an anecdotal observation.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prosperini, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mancinelli, Chiara R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Rossi, Nicola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lugaresi, Alessandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Capobianco, Marco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moiola, Lucia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naldi, Paola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Imberti, Luisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerevini, Simonetta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Capra, Ruggero</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Yuan, Meiling ELSEVIER</subfield><subfield code="t">A new global analytical potential energy surface of NaH</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the World Federation of Neurology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001315870</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:378</subfield><subfield code="g">year:2017</subfield><subfield code="g">day:15</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:233-237</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jns.2017.05.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.10</subfield><subfield code="j">Physikalische Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">378</subfield><subfield code="j">2017</subfield><subfield code="b">15</subfield><subfield code="c">0715</subfield><subfield code="h">233-237</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.398302 |